Top 35 Life Science VC Funds in Denmark
A list of 35 VC funds that invest in Life science startups based in Denmark. We rank investors based on the number of investments they made in Life science companies from Denmark. We update this investor list every month.Top 35 Life Science VC Funds in Denmark
Investor | Life Science Denmark investments |
---|---|
Novo Holdings | 4 |
BioInnovation Institute | 4 |
+ND Capital | 2 |
VF Venture | 2 |
Balderton Capital | 2 |
Sunstone Life Science Ventures | 2 |
Northzone | 2 |
Ysios Capital | 1 |
Sound Bioventures | 1 |
Vaekstfonden | 1 |
Innovation Fund Denmark | 1 |
Teknoinvest | 1 |
Seventure Partners | 1 |
HealthCap | 1 |
Swisscanto Private Equity | 1 |
SLS Venture | 1 |
Industrifonden | 1 |
Vaekstfonden | 1 |
RA Capital Management | 1 |
BlueYard Capital | 1 |
LF Investment | 1 |
Danske Bank | 1 |
Noble Group | 1 |
Nucleus Capital | 1 |
GGV Capital | 1 |
p53 | 1 |
ATP | 1 |
Biofund | 1 |
Innovestor | 1 |
Amino Collective | 1 |
Seed Capital | 1 |
Nordic Alpha Partners | 1 |
Verve Ventures | 1 |
PSV | 1 |
People Ventures | 1 |
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Convertible Note, Pre-Seed, Debt Financing
- Denmark, Germany, Switzerland
Portfolio highlights
- NorFalk — NorFalk rethinks the way to produce surfactants: the active and stabilizing ingredients in household care and personal care consumer products.
- TriptoBIO — TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. Our first compound will liberate the world from rat poison
- HHC Medical — HHC Medical is a health tech company developing targeted non-invasive drug delivery devices through electroporation to transfect a large number of cells. It was founded in 2019 and is headquartered in Hillerød, Denmark.
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Series A
- United States, Switzerland, Denmark
Portfolio highlights
- Vandria — At the vanguard of Mitochondrial research
- Partillion Bioscience — Unlock your research today with the word's first functional single-cell biology reagent platform. Next generation assay kits for single-cell secretion analysis and more.
- PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Funding Round, Series A
- Denmark, United Kingdom, Iceland
Portfolio highlights
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
- Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
- Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.
Show more
Investment focus
- Software, FinTech, Financial Services
- Series B, Series A, Series C
- United Kingdom, United States, Germany
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Tinybird — Tinybird helps data teams build real-time Data Products at scale through SQL-based API endpoints. It ingests millions of rows per second and serves low latency, high concurrency analytical queries over any amount of data.
- ZOE — ZOE analyzes your unique gut, blood fat and blood sugar responses. So you can take back control of your health & weight
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series B, Series A
- Denmark, Sweden, Switzerland
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Northzone is a multi-stage venture capital fund that seeks to invest in the healthcare, semiconductors, software, hardware, artificial intelligence, blockchain, and gaming industries.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Series A, Series B, Seed
- United States, Sweden, United Kingdom
Portfolio highlights
- CuspAI — CuspAI is a revolutionary AI startup that is developing a platform for next-generation materials to address global sustainability and renewable energy concerns. CuspAI uses cutting-edge generative AI, deep learning, and molecular simulation to accelerate the material design process. Their platform works similarly to a search engine for materials,allowing users to request certain properties for new materials on demand.
- Faircado — Stop wasting time and money - faircado helps you find the best pre-owned deals for your wallet and the planet.
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Spain, United States, Switzerland
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
- Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Show more
Investment focus
- Medical, Biotechnology, Therapeutics
- Series A, Seed, Series B
- France, Denmark, United States
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Pre-Seed
- Denmark, United States, United Kingdom
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more
Investment focus
- Software, SaaS, Information Technology
- Grant, Pre-Seed, Seed
- Denmark, United States
Portfolio highlights
- Artelize — Discover events, performers and works within classical music, opera, musical, ballet & dance and drama. 174248 events, and 59606 artists and creators.
- Tryp.com — There is always a reason to go! We use artificial intelligence to find the best travel deals at the lowest price. The algorithm compares and connects flights, trains, and buses to create the perfect multidestination trips with matching hotel offers.
- Curvature AI — Grow your revenue with discounts and special offers selected and optimized by AI.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Funding Round, Series A
- Sweden, Norway, United States
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series A, Series B, Funding Round
- France, United States, Germany
Portfolio highlights
- ID5 — ID5 provides a comprehensive suite of identification services designed to improve to improve addressability and measurement across all environments
- Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
- Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Show more
Investment focus
- Health Care, Manufacturing, Robotics
- Series B, Series C, Funding Round
- Switzerland, Germany, Belgium
Portfolio highlights
- Fotokite — Specialized actively tethered UAS built for First Responders, providing immediate situational awareness of an emergency scene.
- Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus.
The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series C, Funding Round, Series A
- Denmark, United States, Sweden
Portfolio highlights
- AdvanDx — I found a great domain name for sale on Dan.com. Check it out!
- OxThera — OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for thetreatment of primary hyperoxaluria.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Series A, Seed
- Sweden, United States, Denmark
Portfolio highlights
- Arevo — Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
- Telness Tech — We help telcos maximize customer happiness and minimize OPEX through automation. Our proprietary, cloud-based, end-to-end BSS/OSS platform is connectivity ready in 64 countries.
- ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Pre-Seed
- Denmark, United States, Norway
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series C, Series A
- United States, United Kingdom, China
Portfolio highlights
- Idrx — IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.
- MBX Biosciences — Homepage - MBX Biosciences
- Bright Peak Therapeutics — Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties.
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Show more
Investment focus
- Software, Cryptocurrency, Internet
- Seed, Series A, Funding Round
- United States, Germany, France
Portfolio highlights
- Insempra — Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance.
- ExpressionEdits — Redefining the status quo of protein expression
- Transcripta Bio — Transcripta Bio is a company dedicated to drug discovery, with a focus on numerous diseases at once, at a never-before-seen pace and scale, with lesser risk and greater assurance.
LF Investment is the investment arm of The Lauritzen Foundation, which is the parent company of the shipping companies J. Lauritzen (wholly-owned) and DFDS (42,8% holding). LF Investment has holdings in companies in the oil analysis, measuring equipment, software, biotechnology, and real estate sectors.
Show more
Investment focus
- Medical, Wellness, Health Care
- Funding Round
- Denmark
Portfolio highlights
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
Danske Bank is a Nordic universal bank offering a full range of banking services. It was founded 5 October 1871 as Den Danske Landmandsbank, Hypothek- og Vexelbank i Kjøbenhavn (The Danish Farmers' Bank, Mortgage and Exchange Bank of Copenhagen). It is headquartered in Copenhagen, Denmark and is one of the major retail banks in the northernEuropean region with over 5 million retail customers.Danske Bank was number 454 on the Fortune Global 500 list for 2011.
Show more
Investment focus
- Biotechnology, Apps, Payments
- Funding Round, Post-IPO Debt, Debt Financing
- Denmark, Sweden, United States
Portfolio highlights
- FlexQube — FlexQube is a manufacturer and distributor of material handling equipment. They offer a flexible system of a few standard components that can be used to build industrial material handling applications. Their products are pallet carts, kit carts, and shelf carts.
- Rottneros — Rottneros manufactures paper pulp products. They offer mechanical pulp as well as bleached and unbleached chemical pulp. They also offer baking paper, wallpaper, packaging, air filters, electrical applications, datasheets, and laminate floors.
- Renewable Power Capital — Renewable Power Capital invest in the development, construction and long-term ownership of solar, onshore wind and battery storage projects.
Noble Group is a global supply chain manager of energy, power & gas products, metals and carbon steel materials, with interests in key facilities that add value at various stages of its supply chains. Noble Group manages a diversified portfolio of essential natural resources, with integrated sourcing, marketing, processing, financing andtransportation operations. Noble Group's Energy segment encompasses a portfolio of oil liquids and coal products and continues to be a significant driver for the Group’s growth. Gas & Power segment includes their retail energy business Noble Americas Energy Solutions and Gas & Power wholesale operations. In Metals & Mining, Noble Group is one of the world’s leading suppliers with interests in iron ore, aluminium, special ores and alloys across key global locations. The Corporate segment incorporates the Logistics business as well as investments in their major associates. Noble Group (SGX: N21) manages a portfolio of global supply chains covering a range of industrial and energy products. Operating from over 60 locations, Noble facilitates the marketing, processing, financing and transportation of essential raw materials. Sourcing bulk commodities from low cost regions such as South America, South Africa, Australia and Indonesia, the Group supplies high growth demand markets, particularly in Asia and the Middle East. Noble Group is ranked number 77 in the 2015 Fortune Global 500. Noble moves essential resources from producers to consumer across the world. Noble Group's success relies on a rigorously managed balance sheet, effective partnerships and a deep understanding of customer needs. Noble’s core strategy is to be the best company in the world at moving the physical commodity from the producer to the consumer and managing the market, credit and operational risk associated with that. Noble Group's solid financial position comes from a rigorously managed balance sheet with exceptional liquidity and a carefully guided exposure to risk - underpinned by deep relationships with global capital providers. At Noble, they have forged some of the most productive and enterprising partnerships in the industry and they have always believed that as their partners grow, so do they. Noble Group put energy and focus into staying relevant and being valuable to their customers, keeping their interests firmly integrated into their DNA.
Show more
Investment focus
- Medical, Health Care, Genetics
- Funding Round
- Denmark, United Kingdom
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- Digital-Healthcare — Digital Healthcare is a health care company. The company has been acquired by EMIS Group.
Supporting purpose-driven founders solving systemic challenges to planetary health.
Show more
Investment focus
- Biotechnology, Information Technology, Food and Beverage
- Pre-Seed, Seed, Series A
- Germany, United Kingdom, United States
Portfolio highlights
- Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
- Trilobio — Fully automated biology for everyone
- Izote Biosciences — Biomanufacturing Scale-Up Solution
We believe the talent to build great companies comes from anywhere. A global venture capital firm that invests in local founders. As a multi-stage, sector-focused firm, GGV focuses on seed- to growth-stage investments across Social/Internet, Enterprise Tech, and Smart Tech sectors.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Series B, Series A, Series C
- United States, China, Singapore
Portfolio highlights
- UXLINK — UXLINK is a social infrastructure comprised of social protocols and a collection of Dapps.UXLINk creates groundbreaking landing sceneries for web3 groups.
- Jam — Report bugs in seconds, and get back to what you were doing. It's as easy as taking a screenshot. Fast for you, and perfect for the engineers.
- Nozomi Networks — Nozomi Networks keeps operational technology cyber resilient with OT network and endpoint visibility, threat detection, and AI-powered analysis.
p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
Show more
Investment focus
- Biotechnology, Medical, Life Science
- Series A
- Norway, Denmark
Portfolio highlights
- Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board.
The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.
Show more
Investment focus
- Health Care, Health Diagnostics, Software
- Funding Round, Series B
- Denmark
Portfolio highlights
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Visiopharm — Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.
BIOFUND SpA, established by Fondazione Monte dei Paschi, Bank Monte dei Paschi , Finanziaria Senese di Sviluppo e Fidi Toscana, provides the initial seed capital for companies located in the incubator of Toscana Life Sciences in Siena.
Show more
Investment focus
- Genetics, Medical, Health Care
- Funding Round, Seed
- Canada, Denmark, Russian Federation
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- RTM Diagnostika — Diagnostic microwave radio RTM-01-RESThe temperature and rate of growth of malignant tumorsCancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data werefirst obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous.The internal temperature - measure of angiogenesisIn 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.
- Genizon BioSciences — Since 2005, we have helped thousands of people get the perfect domain name.
Welcome to Innovestor! We are a Finnish investment company focusing on venture capital, corporate venturing services, and real estate.
Show more
Investment focus
- Software, Health Care, Manufacturing
- Seed, Funding Round, Series A
- Finland, Denmark, Sweden
Portfolio highlights
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Kausal — Kausal helps cities turn their climate goals into action through a digital platform that enables smarter collaboration around key data.
- Confidentialmind — The ConfidentialMind software stack enables you to integrate AI-solutions such as language models into your workflows and processes without data leaks to third parties. We will find a way to protect your data.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Pre-Seed
- United States, Germany, United Kingdom
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- ExpressionEdits — Redefining the status quo of protein expression
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Funding Round, Series A
- Denmark, United States, United Kingdom
Portfolio highlights
- Flatpay — Flatpay's fair, flat-rate pricing simplifies payments & cuts costs. Benefit from our comprehensive solution & superior customer service. Join us now!
- Mesh Bio — Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patientsbetter manage their health, lifestyle and disease risks.
- Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
Nordic Alpha Partners (NAP) is a growth fund founded in 2017. NAP target companies are typically locally or regionally established players with a revenue of DKK 10-150 mio. and with a global potential that can be fulfilled through new sustainable technologies such as energy storage and 3D print. The company is based in Hellerup, Denmark.We arelooking for:
• SME’s based in Northern Europe with 10-150 MDKK in turnover
• A proposition that either “enables” or “leverages” industrial, green or digital transformation.
• Ambitious teams, looking for capital and/or skills to fuel their growth journeyWe offer truly intelligent capital and partnership via:
• Our “hands on” fund management philosophy
• A vast “value creation framework” supporting rapid business acceleration
• Access to leaders and specialists within global Industry transformation
• A fund management team with extensive operational experience across startups, international business scaling, the industry/technology sector and corporate business
Show more
Investment focus
- Energy, Energy Storage, Renewable Energy
- Funding Round, Seed, Series A
- Denmark, Germany, Sweden
Portfolio highlights
- SunRoof — Roof of the future
- Mater Design — Founded in Copenhagen in 2006, Mater was created to be the pioneering global brand with sustainability embedded in its core. From the very beginning the ambition was to inspire a global design audience and engage people into sustainable thinking.
- Stabl Energy — Stabl Energy is a developer of a technology that significantly improves battery storage systems.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more
Investment focus
- Health Care, Software, Biotechnology
- Series A, Seed, Series B
- Switzerland, Germany, France
Portfolio highlights
- Cubbit — Cubbit is secure encrypted cloud storage with a difference. A distributed cloud that is 100% private and green. Join the Swarm.
- Axelera AI — To accelerate computer vision in edge devices, we offer a powerful, energy-efficient, cost-effective, user-friendly AI hardware and software platform.
- Neustark ag — Neustark enables zero-emissions concrete by capturing concrete production emissions from the atmosphere and permanently converting them to limestone. This climate positive limestone replaces cement and sand which are major cost drivers for concrete production.
PreSeed Ventures are the preferred travel companion for trailblazing founders when they set out on the journey of transforming startup dreams to successful businesses. Founded in 2000 they have an exceptional track record of spotting, fostering and financing tomorrow’s winners in syndication with top-tier investors locally and globally. As the namesuggests, PreSeed Ventures operates at the earliest stages, where founders need the professional, operational & systematic support of a VC, but the risks are still too high for most VCs in seed stages. Yet to the powerhouse of experts behind PreSeed Ventures, who have experience from hundreds of startup journey in the pre-seed stage, it is an opportunity to support and nurture the growth of promising startups on the rise, minimizing the time and risk to the next investment round.PreSeed Ventures has grown out of the technological research environment at Denmark’s Technical University, DTU. In 2020 they launch their first full blown commercial venture fund, yet continuing to be a subsidiary company to the university.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Denmark, United States, United Kingdom
Portfolio highlights
- spektr — Explore spektr's tailored compliance automation solutions for KYB monitoring, AML compliance, risk management, and more. Try our no-code, customizable platform for free today!
- UltiHash — Data powers breakthroughs. UltiHash is the storage foundation to accelerate them: blazing fast, highly efficient, and built for sustainable long-term growth.
- Yacheng Network — Yacheng Network is a provider of information technology and software services that specializes in offering these services.
People Ventures are your dreamcast team of co-founders, investors, executives, engineers, academics and industry experts.
Together with talented entrepreneurs — We shape fantastic businesses through operational and commercial execution.
Show more
Investment focus
- Health Care, Internet of Things, Software
- Seed, Pre-Seed, Series A
- Denmark, Sweden, United States
Portfolio highlights
- Uniify — Uniify is a no-code customer onboarding software that makes it fast, easy and secure for financial companies to onboard their customers. Save your business time and money, and build onboarding flows for your customers in minutes instead of months.
- proemial — Proemial is building an open platform that connects researchers to a larger and more diverse audience through personalized summaries of the latest research papers. The mission is to make it easy to read, discuss, understand and engage with recent discoveries, the researchers that produce them, and the companies that commercialize them.
- Version Lens — Meet your new Product Management Co-Pilot. Reduce overhead for your product team so you can focus on what truly matters, building outstanding products.
Investors by industry
Climate
Community
Gaming
Energy
FinTech
Impact
Biotech
Media (entertainment)
Hardware
Proptech
Marketplace
Artificial intelligence
Consumer
Health Care
EdTech
Sustainability
Agriculture (agtech)
Venture Capital
Photography
B2B
Infrastructure
Education
Food and Beverage
Payments
Video Games
Retail
Fashion
Finance
Publishing
Clean Energy
Financial Services
Big Data
Web3
Beauty
Oil and Gas
Real Estate
Organic Food
Travel
Medical
Social Network
Recruiting
Wellness
Android
Cannabis
Social Media
Digital Media
Google
Mobile
Biotechnology
Franchise
Music
Fitness
Sports
Facebook
Legal
eSports
Platforms
Local
Construction
Email
Hospitality
Enterprise Software
Internet
Art
Mobile Advertising
Manufacturing
Medical Device
CleanTech
Automotive
Transportation
Wine And Spirits
Mobile Apps
Crowdfunding
InsurTech
Enterprise
Social
Non Profit
LGBT
Theatre
Film
Life Science
Renewable Energy
SaaS
Restaurants
Sporting Goods
Celebrity
Software
Social Impact
Cryptocurrency
Blockchain
Investors by country
South Korea
New Zealand
Germany
Ireland
United States
Australia
India
United Kingdom
Canada
Japan
Vietnam
Sri Lanka
China
Saudi Arabia
Middle East
Africa
Oceania
Asia
Europe
Indonesia
Singapore
Spain
Armenia
LATAM
Brazil
Qatar
South Africa
Georgia
Bahrain
Belize
Ethiopia
Bermuda
Chile
Costa Rica
France
Estonia
Ghana
Denmark
Kenya
Mexico
Morocco
Belarus
Kazakhstan
Panama
Czech Republic
Kuwait
Cayman Islands
Liberia
Malta
Jersey
Liechtenstein
Norway
Ecuador
Peru
Israel
Malaysia
Egypt
Mauritius
Lithuania
Mali
Philippines
Croatia
Nicaragua
Cambodia
Lebanon
Myanmar
Italy
Portugal
Thailand
Slovenia
Serbia
Sierra Leone
Rwanda
Poland
San Marino
Zimbabwe
Finland
Turkey
Seychelles
Tanzania
Sweden
Puerto Rico
Taiwan
Uruguay
Senegal
Venezuela
El Salvador
Zambia
Tunisia
Uzbekistan
Uganda
Russian Federation
Togo
Ukraine
Hong Kong
Tajikistan
Dominican Republic
Algeria
Azerbaijan
Bahamas
Nigeria
Namibia
Iraq
Iceland
Gibraltar
United Arab Emirates
Honduras
Faroe Islands
Greece
Bolivia
Isle of Man
Hungary
Luxembourg
Barbados
Belgium
Pakistan
Bulgaria
Albania
Bangladesh
Argentina
Romania
Jordan
Grenada
Oman
Cyprus
Latvia
Marshall Islands
Austria
Switzerland
Cameroon
Colombia
Guatemala
VC Funds in Denmark by industry
Restaurants
Financial Services
Media (entertainment)
Big Data
Education
Finance
Payments
Food and Beverage
Video Games
Medical
Medical Device
Fitness
Social Media
Transportation
Internet
Renewable Energy
Manufacturing
Mobile
Software
Blockchain
Sports
eSports
Travel
Hospitality
Biotechnology
FinTech
Enterprise
Consumer
Health Care
Biotech
EdTech
Sustainability
Climate
Energy
Impact
Proptech
SaaS
Artificial intelligence
Agriculture (agtech)
Mobile Apps
Community
Hardware
Beauty
Web3
B2B
Retail
Fashion
Recruiting
Cryptocurrency
Real Estate
Marketplace
Life Science
Legal
Gaming
Wellness
Music
Enterprise Software
CleanTech
Automotive